45.62
Tonix Pharmaceuticals Holding Corp stock is traded at $45.62, with a volume of 1.44M.
It is down -4.36% in the last 24 hours and up +28.58% over the past month.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
See More
Previous Close:
$47.70
Open:
$46.77
24h Volume:
1.44M
Relative Volume:
1.27
Market Cap:
$335.64M
Revenue:
-
Net Income/Loss:
$-121.02M
P/E Ratio:
-4.0515
EPS:
-11.26
Net Cash Flow:
$-114.09M
1W Performance:
+18.13%
1M Performance:
+28.58%
6M Performance:
+305.87%
1Y Performance:
-0.31%
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Company Profile
Name
Tonix Pharmaceuticals Holding Corp
Sector
Industry
Phone
212-980-9155
Address
26 MAIN STREET, SUITE 101, CHATHAM, NY
Compare TNXP with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
TNXP
Tonix Pharmaceuticals Holding Corp
|
45.62 | 350.94M | 0 | -121.02M | -114.09M | -11.26 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
385.65 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
555.13 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
428.14 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
673.15 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
![]()
ONC
Beone Medicines Ltd Adr
|
298.52 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Apr-18-22 | Initiated | Noble Capital Markets | Outperform |
Apr-18-19 | Upgrade | ROTH Capital | Neutral → Buy |
Aug-18-17 | Upgrade | ROTH Capital | Neutral → Buy |
Sep-07-16 | Downgrade | ROTH Capital | Buy → Neutral |
Feb-17-16 | Reiterated | Oppenheimer | Outperform |
Nov-04-15 | Initiated | Cantor Fitzgerald | Buy |
Jun-12-15 | Initiated | Oppenheimer | Outperform |
Feb-17-15 | Reiterated | ROTH Capital | Buy |
Sep-29-14 | Reiterated | ROTH Capital | Buy |
View All
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Latest News
Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators - Benzinga
Tonix Pharmaceuticals Innovation: What’s Next? - timothysykes.com
TNXP’s Race Against Time: Market Buzz Remains High - StocksToTrade
Tonix Pharmaceuticals Holding Corp. Added to Custom Quant Screener TodayMarket Entry and Exit Point Tips From Traders - metal.it
Published on: 2025-08-04 09:31:49 - metal.it
What institutional investors are buying Tonix Pharmaceuticals Holding Corp. stockInvest confidently with professional market insights - Jammu Links News
How does Tonix Pharmaceuticals Holding Corp. compare to its industry peersOutstanding growth strategies - Jammu Links News
When is Tonix Pharmaceuticals Holding Corp. stock expected to show significant growthFree AI-Backed Trading Signals - Jammu Links News
How strong is Tonix Pharmaceuticals Holding Corp. company’s balance sheetCapitalize on high-yield stocks early - Jammu Links News
Should I hold or sell Tonix Pharmaceuticals Holding Corp. stock in 2025Phenomenal wealth increase - Jammu Links News
Is Tonix Pharmaceuticals Holding Corp. a growth stock or a value stockUnprecedented growth rates - Jammu Links News
Published on: 2025-08-03 07:26:37 - Jammu Links News
Does Tonix Pharmaceuticals Holding Corp. stock perform well during market downturnsDynamic profit opportunities - Jammu Links News
How volatile is Tonix Pharmaceuticals Holding Corp. stock compared to the marketUnlock high-yield investment opportunities - Jammu Links News
Why is Tonix Pharmaceuticals Holding Corp. stock attracting strong analyst attentionWealth Building Opportunities For Beginners - Jammu Links News
What are the technical indicators suggesting about Tonix Pharmaceuticals Holding Corp.Chart Pattern Report Backed By Experts - Jammu Links News
Key resistance and support levels for Tonix Pharmaceuticals Holding Corp.Early Entry Picks Before News Breakout Reviewed - metal.it
Tonix launches Move Fibro Forward campaign to support millions living with Fibromyalgia - Proactive financial news
Price Channel Expanding on Tonix Pharmaceuticals Holding Corp.’s ChartLow Risk Swing Trade Opportunities Identified - metal.it
TNXP: 2Q25 Financial Update and Deep Dive Into TNX-1500 - Smartkarma
Published on: 2025-07-29 17:18:40 - metal.it
TNXP: 2Q25 Financial Update and Deep Dive Into TNX-1500… - Yahoo Finance
Published on: 2025-07-29 07:17:10 - metal.it
What are Tonix Pharmaceuticals Holding Corp. company’s key revenue driversBreakthrough financial growth - jammulinksnews.com
What is the risk reward ratio of investing in Tonix Pharmaceuticals Holding Corp. stockDiscover high-impact stocks for your portfolio - jammulinksnews.com
Is Tonix Pharmaceuticals Holding Corp. stock overvalued or undervaluedBuild a portfolio that outperforms consistently - jammulinksnews.com
What makes Tonix Pharmaceuticals Holding Corp. stock price move sharplyHigh-return market picks - jammulinksnews.com
Why Tonix Pharmaceuticals Holding Corp. stock is on top investor watchlistsFree Market Dynamics Reports - metal.it
Published on: 2025-07-26 12:35:26 - metal.it
Tonix Pharmaceuticals Holding Corp. Stock Analysis and ForecastUnprecedented growth rates - PrintWeekIndia
Tonix Pharma’s Unexpected Rise in Stock Value - timothysykes.com
Is TNXP Stock Ready for Takeoff? - StocksToTrade
Is Tonix Pharmaceuticals Holding Corp. a good long term investmentAccelerated profit realization - PrintWeekIndia
What drives Tonix Pharmaceuticals Holding Corp. stock priceHigh-yield market plays - PrintWeekIndia
What analysts say about Tonix Pharmaceuticals Holding Corp. stockFree High-Return Strategy Alerts - PrintWeekIndia
CD40/CD40L Inhibitors Market on Growth Trajectory Driven by Advancements in Autoimmune and Cancer Therapeutics | DelveInsight - The Malaysian Reserve
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):